Coherus BioSciences (NASDAQ:CHRS) reported its Q4 earnings results on Thursday, February 17, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Coherus BioSciences beat estimated earnings by 9.8%, reporting an EPS of $-0.46 versus an estimate of $-0.51.
Revenue was up $37.05 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.12, which was followed by a 6.74% increase in the share price the next day.
Here's a look at Coherus BioSciences's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.22 | -0.17 | 0.06 | 0.23 |
| EPS Actual | -0.34 | -0.36 | 0.01 | 0.23 |
| Revenue Estimate | 91.31M | 89.81M | 96.00M | 115.12M |
| Revenue Actual | 82.50M | 87.64M | 83.03M | 110.42M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
